Literature DB >> 3648073

Preventing chemotherapy-induced alopecia in cancer patients: is scalp cooling worthwhile?

A J Tierney.   

Abstract

Alopecia (hair loss) is often singled out as the most distressing side-effect of cancer chemotherapy treatment. This paper provides a comprehensive and critical review of the research literature on scalp cooling, a procedure introduced to prevent chemotherapy-induced alopecia. In spite of a considerable amount of research (both nursing and medical) over a 15-year period, the evidence on scalp cooling is inconclusive. Although concerned with a specialist issue, this paper may interest the general reader as it illustrates the value of a literature review in raising questions about current practice and in identifying issues for future research.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3648073     DOI: 10.1111/j.1365-2648.1987.tb01336.x

Source DB:  PubMed          Journal:  J Adv Nurs        ISSN: 0309-2402            Impact factor:   3.187


  4 in total

Review 1.  Adverse effects of cancer chemotherapy. An overview of techniques for avoidance/minimisation.

Authors:  M Nicolson; R C Leonard
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

2.  Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapy.

Authors:  I G Ron; Y Kalmus; Z Kalmus; M Inbar; S Chaitchik
Journal:  Support Care Cancer       Date:  1997-03       Impact factor: 3.603

Review 3.  Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches.

Authors:  Paul J Hesketh; Diane Batchelor; Mitch Golant; Gary H Lyman; Nelson Rhodes; Denise Yardley
Journal:  Support Care Cancer       Date:  2004-06-19       Impact factor: 3.603

Review 4.  Scalp hypothermia as a preventative measure for chemotherapy-induced alopecia: a review of controlled clinical trials.

Authors:  V V Shah; T C Wikramanayake; G M DelCanto; C van den Hurk; S Wu; M E Lacouture; J J Jimenez
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-11-24       Impact factor: 6.166

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.